Adagene and Incyte Initiate Combination Trial of Muzastotug for Colorectal Cancer
SAN DIEGO, California, United States, and SUZHOU, China — October 28, 2026 Adagene Inc., a clinical-stage biotechnology company developing...
CRC
Advertisement
Verastem Oncology Advances VS-7375 Across KRAS G12D Cancers
BOSTON, Massachusetts — September 8, 2026 Verastem Oncology announced plans to host an investor event and webcast on October...
Moleculin Reports Positive Interim MIRACLE Trial Data in Venetoclax-Failed AML Patients
HOUSTON, July 31, 2026 Moleculin Biotech, Inc. announced updated positive preliminary blinded interim results from Part A of its...
Multitude Therapeutics Reports Positive AMT-676 Phase I Data
SHANGHAI, China, July 2, 2026 Multitude Therapeutics Co., Ltd. announced encouraging interim Phase I clinical results for its CDH17-directed...
Oncolytics Reports Promising Pelareorep Data in RAS Cancers
SAN DIEGO, California, USA, June 1, 2026 Oncolytics Biotech has announced encouraging preclinical findings for pelareorep in combination with...
Advertisements
Rgenta Shows Early ACC Response Data for RGT-61159
WOBURN, Massachusetts, May 21, 2026 Rgenta Therapeutics announced positive preliminary results from its ongoing Phase 1a/b clinical trial evaluating...
Advertisement
